Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      RECRUITING
      Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
      Description

      This study evaluates the efficacy of rifampin in the treatment of hypercalcemia and/or hypercalciuria in participants with at least one inactivating mutation of the CYP24A1 gene. Eligible subjects will receive rifampin for a total of 16 weeks during this study.

      Conditions
      Idiopathic Infantile Hypercalcaemia - Severe FormGenetic DiseaseHypercalcemia, Idiopathic, of InfancyHypercalciuric HypercalcemiaIdiopathic Infantile Hypercalcemia - Mild FormHypercalciuria
      Talk to us